Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobramycin/Colistin Combination in Cystic Fibrosis
NCT03341741Phase 3Completed
- Sponsor
- University Hospital Tübingen
- Start
- Mar 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of tobramycin in cystic fibrosis (CF) (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Amount of P. aeruginosa in sputum at 30 days. Started Mar 2014; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03341741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03341741.